<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02810093</url>
  </required_header>
  <id_info>
    <org_study_id>6373</org_study_id>
    <nct_id>NCT02810093</nct_id>
  </id_info>
  <brief_title>Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis</brief_title>
  <acronym>SENOMETRY</acronym>
  <official_title>SENOMETRY : Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quantmetry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary purpose :

      To develop a method to automatically extract and structure the information included in
      numerous medical records from breast cancer patients.

      Secondary purpose :

      With this procedure we can analyze the content of ten thousand anonymized textual medical
      records.

      This information should enable us to explore many subjects, such as:

        -  The impact of certain therapeutic procedures

        -  The characteristics of sub-groups of patients

        -  Pregnancy associated breast cancers

        -  Risk factors
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validate the reliability of a computer-based, automatic information retrieval method specific to medical records from breast cancer multidisciplinary meetings</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Breast cancer recurrence rate after some therapeutic procedures</measure>
    <time_frame>6 months</time_frame>
    <description>Study of the recurrence rate of different subgroups of patients where various procedures were performed</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Breast cancer patients between 2000 and 2016</arm_group_label>
    <description>Patients treated for a breast cancer between 2000 and 2016 in the Hospital of Strasbourg (France).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>retrospective medical records analyze</intervention_name>
    <description>Ten thousand medical records (between years 2000 and 2016) will be analyzed</description>
    <arm_group_label>Breast cancer patients between 2000 and 2016</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients (men and women) suffering from an in situ or invasive cancer treated at Hôpitaux
        Universitaires de Strasbourg between years 2000 and 2016.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Majority (age &gt; 18)

          -  Malignant breast tumors

          -  signed informed consent

        Exclusion Criteria:

          -  Benign breast pathology

          -  Patients not initially treated at the Hôpitaux Universitaires de Strasbourg
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carole Mathelin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Strasbourg's University Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Laudamy</last_name>
    <phone>+33 3 88 11 66 88</phone>
    <email>anne.laudamy@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>anatta Razafimanantsoa</last_name>
    <phone>+ 33 3 88 11 54 14</phone>
    <email>anatta.razafimanantsoa@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Strasbourg Hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Mathelin, MD</last_name>
      <phone>03 88 12 78 34</phone>
      <email>carole.mathelin.x@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Karl Neuberger</last_name>
      <email>kneuberger@quantmetry.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2016</study_first_posted>
  <last_update_submitted>June 20, 2016</last_update_submitted>
  <last_update_submitted_qc>June 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Text mining</keyword>
  <keyword>Big Data</keyword>
  <keyword>Machine Learning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

